[Etanercept: does it constitute a risk factor for development of cerebral venous thrombosis?]

Rev Neurol. 2014 Mar 1;58(5):239-40.
[Article in Spanish]

Abstract

Title: Etanercept: constituye un factor de riesgo para el desarrollo de trombosis venosa cerebral?

Publication types

  • Case Reports
  • English Abstract
  • Letter

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Antibodies, Anticardiolipin / blood
  • Antiphospholipid Syndrome / complications*
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy
  • Autoantibodies / blood
  • Consciousness Disorders / etiology
  • Drug Therapy, Combination
  • Emergencies
  • Etanercept
  • Female
  • Humans
  • Hydrocephalus / etiology
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use
  • Paresis / etiology
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Sinus Thrombosis, Intracranial / chemically induced*
  • Sinus Thrombosis, Intracranial / etiology
  • Sinus Thrombosis, Intracranial / immunology
  • Sjogren's Syndrome / drug therapy
  • Sjogren's Syndrome / etiology
  • Tomography, X-Ray Computed
  • beta 2-Glycoprotein I / immunology

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Anticardiolipin
  • Antirheumatic Agents
  • Autoantibodies
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • beta 2-Glycoprotein I
  • Etanercept
  • Methotrexate